Arterial Occlusive Diseases clinical trials
The registry lists 230 studies for Arterial Occlusive Diseases across more than 10 countries. 27 are recruiting or about to start. 75 of them are mainly about Arterial Occlusive Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 14 narrower conditions too, such as Coronary Artery Disease: 8,552 studies, 1,616 open.
Get an email when these change. Save the Arterial Occlusive Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Heart, Lung, and Blood Institute (NHLBI) (9) · C. R. Bard (5) · Beijing Northland Biotech. Co., Ltd. (4) · Cordis Corporation (4) · Medtronic Vascular (4) · Brigham and Women's Hospital (4) · Boston Scientific Corporation (4) · Shenzhen People's Hospital (3)
What is being tested here
Drugs under test in Arterial Occlusive Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Rivaroxaban | 1 | 1 | 2 |
| Minocycline | 1 | 1 | 1 |
| Enoxaparin | 1 | 0 | 1 |
| Heparin | 1 | 0 | 1 |
| Clopidogrel | 0 | 1 | 6 |
| Aspirin | 0 | 0 | 3 |
| Ticagrelor | 0 | 0 | 3 |
| Alfimeprase | 0 | 2 | 3 |
| Nitroglycerin | 0 | 1 | 2 |
| Urokinase-Type Plasminogen Activator | 0 | 1 | 2 |
Drug classes tested here P2Y12 inhibitors 7 · Thrombolytics 6
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 5
- Dec 2026Resoloy Initial Safety Evaluation · MeKo Manufacturing e.K.
- Dec 2026Oxygen-guided Supervised Exercise Therapy · VA Office of Research and Development
- Jan 2027Embolization Treatment of Chronic Refractory Shoulder Tendinopathy · Brigham and Women's Hospital
- Mar 2027Evaluation of Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients With Peripheral Arterial Disease · VivaCell Biotechnology España
- Mar 2027Healthy Adults Aged 18-55, Three Ukrainian Windlass Tourniquets (SICH, DNIPRO GEN 2, PULS) Compared With CAT Gen 7, and Complete Limb Arterial Occlusion Confirmed by Doppler. · Foundation for Expert Deployment for Governance and Economic Growth (EDGE)
Who these studies take
Of the 20 Arterial Occlusive Diseases studies recruiting now, 13 (65%) set no upper age limit and 2 (10%) stop at 75 or younger. 2 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (10%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (10%) | 2 (10%) |
| 18 | 19 (95%) | 19 (95%) |
| 30 | 20 (100%) | 20 (100%) |
| 40 | 20 (100%) | 20 (100%) |
| 50 | 20 (100%) | 20 (100%) |
| 65 | 20 (100%) | 20 (100%) |
| 75 | 18 (90%) | 18 (90%) |
| 85 | 16 (80%) | 16 (80%) |
Across all 230 studies, recruiting or not: 9% stop at 75 or younger and 3% at 65; 6% take children; 0% are for women only and 2% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Arterial Occlusive Diseases studies take
Of 56 interventional studies with no phase under Arterial Occlusive Diseases, half reached primary completion within 27 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 27 mo14–53 · 56 studies | — | 24 mo12–37 · 47 studies |
| Observational | 40 mo8–50 · 23 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 14, 2026.
Studies
Recruiting first, then most recently updated. Showing 50 of 230. Browse all 230 → or search them.
- Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery LesionsRecruitingNCT07258290Not applicable4 countries
- A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)RecruitingNCT07286578Not applicable4 countries
- Healthy Adults Aged 18-55, Three Ukrainian Windlass Tourniquets (SICH, DNIPRO GEN 2, PULS) Compared With CAT Gen 7, and Complete Limb Arterial Occlusion Confirmed by Doppler.Not yet recruitingNCT07900360Not applicable
- Radial Access Data in Vascular Interventions RegistryRecruitingNCT076143861 country
- Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular DiseaseNot yet recruitingNCT07658807Phase 31 country
- Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)RecruitingNCT06890312Not applicable1 country
- Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)RecruitingNCT07594301Phase 2/31 country
- Safety and Efficacy of CAG and PCI Via Distal Transradial Access in Patients With Small VesselsRecruitingNCT07410364Not applicable1 country
- Embolization Treatment of Chronic Refractory Shoulder TendinopathyRecruitingNCT06095050Not applicable1 country
- Transulnar Access in Patients With Ipsilateral Radial Artery Occlusion Undergoing Coronary Angiography or AngioplastyRecruitingNCT073803991 country
- Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery OcclusionRecruitingNCT06981624Not applicable1 country
- Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)RecruitingNCT06535568Not applicable1 country
- Oxygen-guided Supervised Exercise TherapyRecruitingNCT06003855Not applicable1 country
- Evaluation of Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients With Peripheral Arterial DiseaseNot yet recruitingNCT06774040Phase 21 country
- Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic StrokeRecruitingNCT05930145Not applicable2 countries
- Impact of Preprocedural Stress Ball Use on Radial Artery Outcomes in Elective Coronary AngiographyNot yet recruitingNCT07087522Not applicable1 country
- Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)Enrolling by invitationNCT070239651 country
- Radial Artery Occlusion and Dual Artery Hemostasis After Transradial Approach.RecruitingNCT049331361 country
- Comparison of 6F and 7F Sheaths for Coronary Intervention Via Distal Radial Artery AccessEnrolling by invitationNCT06585917Not applicable1 country
- Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac CatheterizationRecruitingNCT06812455Phase 41 country
- Validation of a Magnetic Sensor in Arterial Flow Recording, Compared With the Reference Method, at Various Peripheral Arterial SitesRecruitingNCT06274697Not applicable1 country
- Spectroscopy in Functional Assessment of Peripheral Artery Disease (spectroAMI)RecruitingNCT037234731 country
- Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion ChemotherapyRecruitingNCT06293287Phase 21 country
- Standard vs High Dose of Unfractionated Heparin in the Incidence of Radial Artery Occlusion (DEFINITION) Trial.RecruitingNCT04561648Not applicable1 country
- Distal Radial Access for Coronary ProceduresRecruitingNCT061654061 country
- The North Kynouria ProjectRecruitingNCT06115213Not applicable1 country
- Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.Not yet recruitingNCT03423511Not applicable
- Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy SystemCompletedNCT073353411 country
- Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity RevascularizationActive, not recruitingNCT07597239Not applicable1 country
- A Study on the Application of Simple and Improved Radial Artery Compression Method After Transradial Coronary InterventionCompletedNCT06787287Not applicable1 country
- Detection of Cerebral Ischemia With Artificial Intelligence.CompletedNCT039193701 country
- Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)CompletedNCT032536921 country
- Trial Using Integuseal as Microbial Sealant for Arterial Bypass Surgery on Lower ExtremitiesTerminatedNCT00940979Not applicable1 country
- CES1 Carriers in the PAPI StudyCompletedNCT03188705Phase 41 country
- IRIS-Onyx Cohort in the IRIS-DES RegistryActive, not recruitingNCT025939941 country
- Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI TrialActive, not recruitingNCT04310046Not applicable6 countries
- Resoloy Initial Safety EvaluationActive, not recruitingNCT07648017Not applicable1 country
- Manual vs Pneumatic Compression to Prevent Radial Artery Occlusion After Transradial ProceduresCompletedNCT07621185Not applicable1 country
- Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery DiseaseCompletedNCT042295631 country
- Use of Various Types of Introducers in Conventional Radial AccessCompletedNCT07572422Not applicable1 country
- Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery OcclusionTerminatedNCT03630055Phase 32 countries
- A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal ArteriesCompletedNCT030374115 countries
- Intraosseous Doppler Ultrasonography to Study Skeletal Physiology: Exploratory Study Before Use in Space PhysiologyCompletedNCT06206031Not applicable1 country
- Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST TrialCompletedNCT06549842Not applicable2 countries
- Multivessel TALENTActive, not recruitingNCT04390672Not applicable1 country
- The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PADCompletedNCT04089943Not applicable1 country
- Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy ClosureWithdrawnNCT05468957Not applicable1 country
- Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)CompletedNCT04624854Phase 41 country
- A Clinical and Histological Analysis of Mesenchymal Stem Cells in AmputationCompletedNCT02685098Phase 11 country
- FLEX FIRST Registry Research ProtocolCompletedNCT056161041 country